Two giant pharmaceutical companies should lower the price of a new vaccine against pneumococcal disease that is needed by children in developing countries, but is unaffordable for some of their governments, say the volunteer doctors of Medecins sans Frontieres . In a report on vaccine pricing, MSF says British company GlaxoSmithKline and US giant Pfizer should slash the price of the vaccines to US$5 per child in developing countries.